Collectively, the multi-omic interrogation approach utilised here reaffirmed their oncogenic potential, clarified molecular drivers of their deregulation, and identified new interesting NAT-cancer connections that can be the focus of future studies. The gene discussed is BRD2; the disease is cancer.